![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Neogene Therapeutics
Neogene Therapeutics is now a part of the AstraZeneca Group. Visit AstraZeneca.com. AstraZeneca.com ...
Notice at Collection for California Job Applicants - Neogene …
Neogene Therapeutics, Inc. (the “Company”) is providing you with this Notice at Collection for California Job Applicants (“Notice”) to inform you about: the categories of Personal Information …
Neogene Therapeutics
Neogene T-Cell Processing. Sign in with Neogene Sign in with AstraZeneca
Neogene Cookie Policy
Our website, https://www.neogene.com (hereinafter: “the Website”) uses cookies and other related technologies (for convenience all technologies are referred to as “cookies”). Cookies …
Cookie Policy - Neogene Therapeutics
Our website, https://www.neogene.com (hereinafter: "the website") uses cookies and other related technologies (for convenience all technologies are referred to as "cookies"). Cookies are also …
Engineering TGF-β-resistant TCR-edited T cells for mutant TP53-targeted cancer immunotherapy Vanessa Tubb, Sander Eshuis, Paula Kroon, Xiangjun Kong, Ton N.M. Schumacher,
Pipeline - Neogene Therapeutics
Neogene Therapeutics, Inc. 2225 Colorado Ave Santa Monica, CA 90404 United States
Management Archives - Page 2 of 2 - Neogene Therapeutics
Dr. Perez Garcia is the Vice President of Translational Sciences at Neogene Therapeutics. She has more than 16 years of combined academic and biopharma industry experience in cancer …
News Archives - Page 2 of 2 - Neogene Therapeutics
Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies
Management Archives - Neogene Therapeutics
Sarah Cohen, MD, is Vice President, Head of Clinical Development at Neogene Therapeutics. She is a physician-scientist experienced in drug development strategy from the pre-IND to first …
- Some results have been removed